drugset / Trial / NCT02047552
RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this trial is to determine if the combination of goal directed iron supplementation and hepcidin mitigation can safely eliminate both the serum and bone marrow iron debt of anemic, critically ill trauma patients with functional iron deficiency.
Timeline
- Start
- 2015-01
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron sucrose | Unknown | 100 mg | Intravenous |
| Subject | Oxandrolone | Small molecule | 10 mg | Oral |